HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2414461Generated: October 25, 2026
Citalopram → 2-Hydroxymethyl-4-bromo-4'-fluorobenzophenone
https://huagongshe.com/reaction/2414461
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Citalopram | HCID 2771 | — |
| Reactant | 1-Bromo-4-fluorobenzene | HCID 9993 | — |
| Reactant | 5-Bromophthalide | HCID 603144 | — |
| Reactant | Magnesium | HCID 5462224 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Product | 2-Hydroxymethyl-4-bromo-4'-fluorobenzophenone | HCID 9922663 | — |
Reaction Steps
The preparation of citalopram and its hydrobromide salt from 5-bromophthalide and the properties of such compounds was first reported in U.S. Pat. No. 4,136,193, which corresponds to German Offenlegungsschrift No. 2,657,013. U.S. Pat. No. 4,136,193 discloses a synthesis of citalopram starting from 5-bromophthalide, which involves the use of two successive Grignard reactions. In a first reaction, a Grignard reagent prepared from p-fluorobromobenzene and magnesium turnings in ether was reacted with 5-bromophthalide to give 2-hydroxymethyl-4-bromo-4′-fluorobenzophenone. The latter was isolated as a crude oil before, in a second reaction, being added to N,N-dimethylaminopropylymagnesium chloride to give (4-bromo-2-(hydroxymethyl)phenyl)-(4′-fluorophenyl)-(3-dimethylaminopropyl)-methanol. The latter was dehydrated with 60 aqueous phosphoric acid to yield 1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane, which was then refluxed with cupric cyanide in dimethylformamide to give citalopram.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06812355B2 |
|---|
| Source dataset | uspto-grants-2004_11 |
|---|
| ORD ID | ord-cadd4e71058441c8984010d7c6a1a8a3 |
|---|
| Source note | uspto-grants-2004_11 |
|---|